Your browser doesn't support javascript.
loading
Involvement of single nucleotide polymorphisms of junction adhesion molecule with small vessel vascular dementia.
Xie, Peter; Kancherla, Kiran; Chandramohan, Sashiruben; Braidy, Nady; Chan, Eunice Kar Wing; Xu, Ying Hua; Chan, Daniel K Y.
Afiliación
  • Xie P; Faculty of Medicine University of New South Wales Sydney New South Wales Australia.
  • Kancherla K; Faculty of Medicine University of New South Wales Sydney New South Wales Australia.
  • Chandramohan S; Faculty of Medicine University of New South Wales Sydney New South Wales Australia.
  • Braidy N; Faculty of Medicine University of New South Wales Sydney New South Wales Australia.
  • Chan EKW; Ingham Institute Liverpool New South Wales Australia.
  • Xu YH; Centre for Healthy Brain Ageing, School of Psychiatry University of New South Wales Sydney New South Wales Australia.
  • Chan DKY; Faculty of Medicine Western Sydney University Macarthur New South Wales Australia.
Aging Med (Milton) ; 6(4): 347-352, 2023 Dec.
Article en En | MEDLINE | ID: mdl-38239713
ABSTRACT

Objectives:

It is now recognized that blood brain barrier (BBB) leakage occurs in cerebral small vascular disease (CSVD) and plays a significant role in the pathophysiology of vascular dementia. We hypothesized that genetic polymorphisms of junctional adhesion molecule-A (JAM-A) (which may result in compromised structure of tight junction proteins that form the BBB) in combination with cerebrovascular risk factors hypertension, lipid disorders, and type 2 diabetes may result in BBB leakage and increase the individual's risk of CSVD-related dementia.

Methods:

In this case-control study, 97 controls with a mean Mini-Mental State Exam (MMSE) score of 29 and 38 CSVD-related vascular dementia participants (mean MMSE score of 19) were recruited. Bloods were collected for the analysis of two common single nucleotide polymorphisms (SNPs) of the JAM-A genotypes rs790056 and rs2481084 using real-time polymerase chain reaction (PCR) assay. Medical history of hypertension, hyperlipidemia, and diabetes was collected for all participants.

Results:

Polymorphisms of genotype JAM-A SNP rs790056 showed statistically significant result when the subgroup with hyperlipidemia was analyzed (OR = 3.130, p = 0.042 for TC + CC genotypes with hyperlipidaemia vs controls). Similar result was found with diabetes (OR = 4.670, p = 0.031 for TC + CC genotypes vs controls). No significant result was found with hypertension. Borderline results of statistical significance were found for JAM-A SNP rs2481084 with hyperlipidemia (OR = 3.210, p = 0.054 for TC + CC genotypes vs controls) and with diabetes (OR = 3.620, p = 0.069 for TC + CC genotypes vs controls) but not for hypertension. The borderline results might have been due to lack of statistical power because of small sample size.

Conclusions:

These results lend further support that cerebrovascular risk factors interact with genetic polymorphisms of BBB proteins to increase the risk of vascular dementia.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Aging Med (Milton) Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Aging Med (Milton) Año: 2023 Tipo del documento: Article
...